Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-10 4:44 pm Purchase | 13G | AN2 THERAPEUTICS INC ANTX | Frazier Life Sciences Public Fund L.P. | 1,488,889 5% | 1,488,889 (New Position) | View |
| 2024-04-09 4:26 pm Purchase | 13G | ELEVATION ONCOLOGY INC ELEV | Frazier Life Sciences Public Fund L.P. | 2,958,579 6.1% | 2,958,579 (New Position) | View |
| 2024-03-29 10:40 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Frazier Life Sciences Public Fund L.P. | 2,631,713 5.4% | 2,631,713 (New Position) | View |
| 2024-02-22 1:22 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund L.P. | 3,687,867 8.9% | 105,573 (+2.95%) | View |
| 2024-02-13 12:44 pm Sale | 13G | GRITSTONE BIO INC GRTS | Frazier Life Sciences Public Fund L.P. | 1,092,185 1.1% | -4,131,470 (-79.09%) | View |
| 2024-02-13 12:36 pm Sale | 13G | THESEUS PHARMACEUTICALS INC CO THRX | Frazier Life Sciences Public Fund L.P. | 0 0% | -2,248,194 (Position Closed) | View |
| 2024-02-09 11:41 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Frazier Life Sciences Public Fund L.P. | 10,416,666 11% | 10,416,666 (New Position) | View |
| 2024-01-25 1:24 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | Frazier Life Sciences Public Fund L.P. | 4,142,855 6.2% | 4,142,855 (New Position) | View |
| 2023-12-14 1:33 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund L.P. | 3,582,294 10.4% | 343,435 (+10.60%) | View |
| 2023-10-05 12:23 pm Sale | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Frazier Life Sciences Public Fund L.P. | 0 0% | -3,708,838 (Position Closed) | View |
| 2023-09-27 10:26 am Purchase | 13D | HILLEVAX INC HLVX | Frazier Life Sciences Public Fund L.P. | 9,806,472 20.2% | 25,000 (+0.26%) | View |
| 2023-05-26 5:29 pm Purchase | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences Public Fund L.P. | 10,125,788 18.5% | 1,697,683 (+20.14%) | View |
| 2023-05-05 4:13 pm Purchase | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences Public Fund L.P. | 8,428,105 19.3% | 8,428,105 (New Position) | View |
| 2023-05-05 4:12 pm Purchase | 13D | HILLEVAX INC HLVX | Frazier Life Sciences Public Fund L.P. | 9,781,472 25% | 144,240 (+1.50%) | View |
| 2023-04-17 5:29 pm Sale | 13G | ALLAKOS INC ALLK | Frazier Life Sciences Public Fund L.P. | 392,269 0.5% | -4,399,731 (-91.81%) | View |
| 2023-02-14 12:19 pm Sale | 13G | COGENT BIOSCIENCES INC COGT | Frazier Life Sciences Public Fund L.P. | 2,109,154 3% | -78,850 (-3.60%) | View |
| 2023-02-14 12:19 pm Sale | 13G | TRICIDA INC TCDA | Frazier Life Sciences Public Fund L.P. | 1,500,000 2.5% | -2,082,093 (-58.13%) | View |
| 2023-02-14 12:12 pm Purchase | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Frazier Life Sciences Public Fund L.P. | 3,708,838 5.4% | 936,776 (+33.79%) | View |
| 2023-02-14 12:09 pm Purchase | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | Frazier Life Sciences Public Fund L.P. | 3,746,857 2.2% | 16,200 (+0.43%) | View |
| 2023-02-14 12:08 pm Purchase | 13G | GRITSTONE BIO INC GRTS | Frazier Life Sciences Public Fund L.P. | 5,223,655 6.3% | 495,104 (+10.47%) | View |